Investment Holding Companies

HEALTHCARE AI ACQUISITION CORP C/WTS (TO PUR COM)

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

HAIAF

HAIWF

HAIUF

Healthcare AI Acquisition Corp. has issued a $196,919.23 unsecured, non-interest-bearing promissory note to Leading Group Limited for short-term financing, with repayment due by October 14, 2026. The company also amended two earlier notes to align their maturity with key transaction events. This financing strategy aims to provide flexibility in completing a merger while ensuring cash repayment in case of liquidation. Healthcare AI Acquisition focuses on structuring and financing mergers rather than traditional healthcare or AI products, with a current market cap of $71.23M.

Tip Ranks

HEALTHCARE AI ACQUISITION CORP

HEALTHCARE AI ACQUISITION CORP UNIT 1 CL A COM & 1/2 WT EXP(07/12/2026)

Healthcare AI Acquisition Secures New Short-Term Financing Note

AIDX

Roth MKM analyst Kyle Bauser has reiterated a Buy rating on HEALWELL AI (AIDX) with a price target of C$2.50. Despite Bauser's average return of -12.4% and a 36.90% success rate, the consensus on HEALWELL AI remains a Strong Buy, with an average price target of C$3.03 according to TipRanks.

20/20 Biolabs

HEALWELL AI (AIDX) Gets a Buy from Roth MKM

VSAI

HEALWELL AI Expands DARWEN Platform’s Scientific Footprint With 47 Peer-Reviewed Studies

Verses AI

C3.AI

HEALWELL AI Expands DARWEN Platform’s Scientific Footprint With 47 Peer-Reviewed Studies

Stifel Nicolaus analyst Justin Keywood has maintained a Buy rating on HEALWELL AI (AIDX) with a price target of C$3.80. The analyst consensus for HEALWELL AI is a Strong Buy, with an average price target of C$3.20. Keywood focuses on the Healthcare sector and has an average return of -3.5% with a 48.85% success rate on his stock recommendations.

Stifel Nicolaus Remains a Buy on HEALWELL AI (AIDX)

HEALWELL AI has secured a multi-million dollar, multi-year Health Information Exchange (HIE) software contract in the U.S., enhancing its data interoperability capabilities. This contract will facilitate the secure exchange of healthcare data across various providers, improving care coordination and population health reporting. The company is also experiencing strong momentum in its software pipeline, with ongoing renewals and new bids across multiple regions. Additionally, HEALWELL has integrated AI capabilities into its Orion Amadeus platform, further strengthening its competitive position in the healthcare market.

- HEALWELL AI Inc. has secured a multi-million dollar Health Information Exchange (HIE) software contract in the U.S., enhancing its data interoperability footprint.  
- The contract aims to aggregate and exchange healthcare data among various providers, improving care coordination and supporting population health efforts.  
- The company's continued momentum includes integration of AI capabilities within its software, positioning HEALWELL for long-term growth across multiple regions.

StockTitan

SPDR S&P Software

iShares Expanded Tech Software Sector ETF

HEALWELL AI Announces Multi-Million Dollar U.S. Health Information Exchange Contract and AI-Driven Pipeline Momentum | HWAIF Stock News

HEALWELL AI has signed its first contract to deliver AI solutions in the Middle East, marking a significant step in its global expansion. The company is deploying its SMART Identify, SMART Search, and SMART Summary solutions across healthcare systems in Canada and the U.S., enhancing patient care and operational efficiency. HEALWELL's AI technology is now actively used in multiple healthcare environments, demonstrating its scalability and commitment to improving healthcare outcomes. The company continues to build its AI-as-a-Service model, with a growing pipeline of opportunities across various regions.

HEALWELL AI Expands Global Footprint with First AI Implementation in Middle East and Growing Enterprise Adoption Across Canada and the United States | HWAIF Stock News

WELL

HCWC

WGRX

HEALWELL AI and WELL Health have launched WELLTRUST™, a consent-first platform for ethical patient identification in clinical research. This initiative combines WELL's clinical network with HEALWELL's DARWEN™ AI to enhance recruitment for clinical trials while ensuring patient privacy. Patients can consent to be contacted about research opportunities, and those who opt-out can continue receiving care as usual. The platform aims to improve healthcare outcomes and accelerate research by creating a scalable, compliant data infrastructure for patient engagement in clinical studies.

VG Health

Welltower Op

Healthy Choice Wellness

VanEck Pharmaceutical ETF

iShares US Healthcare Providers

Invesco Pharmaceuticals ETF

Wellgistics Health

SPDR S&P Health

iShares Global Healthcare

HEALWELL AI and WELL Health Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research | HWAIF Stock News

CLOU

Gianluca Tucci from Haywood has maintained a Buy rating on HEALWELL AI with a price target of C$4.50, citing a strengthening operating engine and monetization opportunities. Key developments include progress in commercial collaboration with Orion, the upcoming Amadeus AI launch, and integration of Khure and Pentavere into the DARWIN engine. These factors are expected to drive revenue growth from 2026. Roth MKM also reiterated a Buy rating with a C$2.50 price target.

- Gianluca Tucci from Haywood has reiterated a Buy rating on HEALWELL AI with a price target of C$4.50, citing the company's strengthening operating engine and emerging monetization opportunities.  
- Key developments such as the completion of integration work, commercial collaboration with Orion, and the impending launch of Amadeus AI are expected to drive revenue growth from 2026 onwards.  
- Roth MKM also maintained a Buy rating on HEALWELL AI, setting a lower price target of C$2.50.

Global X Cloud Computing ETF

ISHRS S&P Glb It

HEALWELL AI: Strengthening Operating Engine, Orion Partnership, and Amadeus AI Launch Underpin Buy Rating and Long-Term SaaS Growth

Roth MKM analyst Kyle Bauser maintained a Buy rating on HEALWELL AI (AIDX) with a price target of C$2.50. Bauser has an average return of -12.4% and a 37.86% success rate, focusing on the Healthcare sector. Scotiabank's Kevin Krishnaratne also issued a Buy rating on February 4, while TipRanks reiterated a Hold rating on the same day.

Roth MKM Keeps Their Buy Rating on HEALWELL AI (AIDX)

SBIO

GXAI

HEALWELL AI has provided a corporate update detailing significant progress in integrating its AI capabilities into a unified platform powered by DARWEN™. The company is expanding its offerings through commercial initiatives with Orion-Verosource, enhancing upsell and cross-sell opportunities. HEALWELL is also launching Amadeus AI in North America and plans international expansion. The company is focused on portfolio simplification and strategic investments, including a $2 million investment in xAI, now part of SpaceX. Overall, HEALWELL aims to strengthen its position in the healthcare AI market through improved integration and commercial traction.

Invesco Biotechnology & Genome ETF

ALPS Medical Breakthrough

Gaxos.ai

YieldMax AI Option Income Strategy ETF

Proshares Ultra Nasdaq Biotech

SPDR S&P Biotech

VanEck Biotech ETF

First Trust NYSE Arca Biotech Index Fd

Virtus Artificial Intelligence & Tech Opportunities Fd

iShares Biotechnology ETF

HEALWELL AI Provides Corporate Update Highlighting Platform Integration Progress, Embedded AI Expansion and Continued Portfolio Simplification | HWAIF Stock News

HEALTHCARE AI ACQUISITION CORP C/WTS (TO PUR COM)(HAIWF.US)

Healthcare AI Acquisition Secures New Short-Term Financing Note

HEALWELL AI (AIDX) Gets a Buy from Roth MKM

HEALWELL AI Expands DARWEN Platform’s Scientific Footprint With 47 Peer-Reviewed Studies

Stifel Nicolaus Remains a Buy on HEALWELL AI (AIDX)

HEALWELL AI Announces Multi-Million Dollar U.S. Health Information Exchange Contract and AI-Driven Pipeline Momentum | HWAIF Stock News

HEALWELL AI Expands Global Footprint with First AI Implementation in Middle East and Growing Enterprise Adoption Across Canada and the United States | HWAIF Stock News

HEALWELL AI and WELL Health Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research | HWAIF Stock News

HEALWELL AI: Strengthening Operating Engine, Orion Partnership, and Amadeus AI Launch Underpin Buy Rating and Long-Term SaaS Growth

Roth MKM Keeps Their Buy Rating on HEALWELL AI (AIDX)

HEALWELL AI Provides Corporate Update Highlighting Platform Integration Progress, Embedded AI Expansion and Continued Portfolio Simplification | HWAIF Stock News